Structures by: García-Báez E. V.
Total: 53
N-(2-hydroxyethyl)-2-oxo-2H-chromene-3-carboxamide
C12H11NO4
CrystEngComm (2009) 11, 7 1451
a=17.372(4)Å b=5.1248(13)Å c=11.968(3)Å
α=90° β=103.925(4)° γ=90°
6-chloro-N-(2-hydroxyethyl)-2-oxo-2H-chromene-3-carboxamide
C12H10ClNO4
CrystEngComm (2009) 11, 7 1451
a=5.3567(5)Å b=22.078(2)Å c=9.3087(8)Å
α=90° β=91.873(2)° γ=90°
N-(2-hydroxyethyl)-6-methoxy-2-oxo-2H-chromene-3-carboxamide
C13H13NO5
CrystEngComm (2009) 11, 7 1451
a=6.8051(14)Å b=24.947(5)Å c=8.097(3)Å
α=90° β=123.45(2)° γ=90°
C12H10BrNO4
C12H10BrNO4
CrystEngComm (2009) 11, 7 1451
a=8.2813(7)Å b=25.012(2)Å c=5.5283(5)Å
α=90° β=94.459(2)° γ=90°
N-(2-hydroxyethyl)-6-nitro-2-oxo-2H-chromene-3-carboxamide hydrate
C12H12N2O7
CrystEngComm (2009) 11, 7 1451
a=5.0399(13)Å b=8.901(2)Å c=14.031(4)Å
α=94.044(4)° β=91.533(4)° γ=90.092(4)°
Diethyl N,N'-[1,3-(2,4,6-trimethyl)phenylene]dioxamalate
C17H22N2O6
CrystEngComm (2011) 13, 14 4748
a=8.0020(3)Å b=15.7340(5)Å c=14.3370(6)Å
α=90° β=102.76(4)° γ=90°
Diethyl N,N'-[1,3-(2-methyl)phenylene]dioxamalate
C15H18N2O6
CrystEngComm (2011) 13, 14 4748
a=8.2302(12)Å b=23.218(3)Å c=8.1795(12)Å
α=90.00° β=94.665(2)° γ=90.00°
N,N-Bis[(2-(2-hydroxyethylamino)oxalyl)]-1,3- (5-tertbuthyl-2-methoxy)phenylenediamine
C19H28N4O7
CrystEngComm (2011) 13, 14 4748
a=13.066(3)Å b=24.384(5)Å c=13.303(3)Å
α=90° β=90.00(3)° γ=90°
N,N'-Bis(2-(2-hydroxyethylamino)oxalyl)-1,3-(2-methyl) phenylenediamine
C15H20N4O6
CrystEngComm (2011) 13, 14 4748
a=9.0080(18)Å b=9.5510(19)Å c=10.5930(19)Å
α=94.80(2)° β=99.01(3)° γ=109.34(3)°
N,N'-Bis-[2-(2-(2-hydroxyethoxy)ethylamino) oxalyl]-1,3-(2,4,6-trimethyl)phenylenediamine
C21H32N4O8
CrystEngComm (2011) 13, 14 4748
a=11.4567(6)Å b=12.9050(7)Å c=16.4558(10)Å
α=90.00° β=101.828(2)° γ=90.00°
Diethyl N,N'-[1,3-(2,4,6-trimethyl)phenylene]dioxamalate
C17H22N2O6
CrystEngComm (2011) 13, 14 4748
a=8.0352(7)Å b=16.0173(14)Å c=14.3980(14)Å
α=90° β=102.681(2)° γ=90°
Diethyl N,N'-(1,3-(5-tert-buthyl-2- methoxy)phenylene)dioxamalate
C19H26N2O7
CrystEngComm (2011) 13, 14 4748
a=9.9640(3)Å b=10.2180(3)Å c=10.5790(4)Å
α=80.969(2)° β=87.691(2)° γ=87.649(1)°
N-(3-hydroxypyridine)-N'-(2-methoxyphenyl)oxamide
C14H15N3O5
Journal of the Chemical Society, Perkin Transactions 2 (2001) 9 1817
a=12.825(3)Å b=15.110(3)Å c=7.3410(10)Å
α=90.00° β=101.02(3)° γ=90.00°
N-(3-hydroxypyridine)-N'-(2-nitrophenyl)oxamide
C16H17N5O6
Journal of the Chemical Society, Perkin Transactions 2 (2001) 9 1817
a=7.2193(4)Å b=14.6988(7)Å c=16.6931(8)Å
α=90.00° β=91.3250(1)° γ=90.00°
1,3-Bis(trimethylsilyl)-1<i>H</i>-benzimidazole-2(<i>3H</i>)-thione
C13H22N2SSi2
Acta Crystallographica Section C (2015) 71, 9
a=10.0302(3)Å b=10.6172(3)Å c=16.2428(6)Å
α=90° β=90° γ=90°
1-Trimethylsilyl-1<i>H</i>-benzimidazole-2(<i>3H</i>)-thione
C10H14N2SSi
Acta Crystallographica Section C (2015) 71, 9
a=9.8057(2)Å b=15.8032(4)Å c=15.8658(5)Å
α=90° β=93.8590(10)° γ=90°
3-Acetyl-8-methoxy-2<i>H</i>-chromen-2-one
C12H10O4
Acta Crystallographica Section E (2019) 75, 12 1866-1870
a=9.4973(13)Å b=7.9733(11)Å c=26.682(4)Å
α=90° β=90° γ=90°
<i>N^2^</i>,<i>N^2'^</i>-bis[2-(morpholin-4-yl)propyl]- <i>N^1^</i>,<i>N</i>^1'^-(1,2-phenylene)dioxalamide dimethyl sulfoxide monosolvate
C24H36N6O6,C2H6OS
Acta crystallographica. Section C, Crystal structure communications (2013) 69, Pt 1 66-69
a=8.6704(8)Å b=11.0052(10)Å c=16.3277(15)Å
α=107.425(2)° β=98.036(2)° γ=91.517(2)°
Diethyl N,N'-cyclohexane-1,4-diyldioxalamate
C14H22N2O6
Acta Crystallographica Section E (2005) 61, 9 o2994-o2996
a=13.145(3)Å b=7.2093(15)Å c=8.6617(17)Å
α=90° β=106.709(3)° γ=90°
C14H16N2O6
C14H16N2O6
Acta Crystallographica Section E (2003) 59, 6 o825-o827
a=25.086(5)Å b=7.1225(14)Å c=8.2529(17)Å
α=90.00° β=104.870(3)° γ=90.00°
2-aminobenzothiazole--N-benzyl-2-oxo-2H-1-benzopyran-3-carboxamide (1/1)
C7H6N2S,C17H13NO3
Acta Crystallographica Section E (2003) 59, 11 o1628-o1630
a=6.833(2)Å b=12.526(4)Å c=12.786(4)Å
α=104.903(5)° β=93.392(5)° γ=94.425(5)°
Dimethyl N,N'-(1,2-phenylene)dicarbamate
C10H12N2O4
Acta Crystallographica Section E (2004) 60, 9 o1488-o1490
a=9.3056(19)Å b=4.8400(10)Å c=11.843(2)Å
α=90.00° β=100.181(3)° γ=90.00°
1,1,2,2-Tetrachloro-1,2-diphenylethane
C14H10Cl4
Acta Crystallographica Section E (2005) 61, 3 o678-o680
a=8.5925(10)Å b=10.6129(13)Å c=7.7558(9)Å
α=90° β=114.315(2)° γ=90°
Di-μ-diphenylphosphido-bis[tricarbonyliron(II)] dichloromethane solvate
C30H20Fe2O6P2,CH2Cl2
Acta Crystallographica Section E (2005) 61, 8 m1475-m1477
a=11.3218(11)Å b=12.7214(13)Å c=11.8011(12)Å
α=90° β=105.976(2)° γ=90°
1,1',3,3'-Tetrabenzyl-2,2'-biimidazolidine
C34H38N4
Acta Crystallographica Section E (2005) 61, 8 o2464-o2466
a=5.83840(10)Å b=9.6253(2)Å c=25.7216(4)Å
α=90° β=93.4210(10)° γ=90°
(E)-3-Nitrobenzaldehyde O-acetyloxime
C9H8N2O4
Acta Crystallographica Section E (2004) 60, 8 o1451-o1452
a=8.3129(11)Å b=11.2119(15)Å c=10.2947(14)Å
α=90.00° β=92.769(2)° γ=90.00°
N-Cyclohexyl-2-oxo-2H-1-benzopyran-3-carboxamide
C16H17NO3
Acta Crystallographica Section E (2004) 60, 12 o2306-o2308
a=6.0870(14)Å b=9.529(2)Å c=12.021(3)Å
α=93.682(4)° β=96.977(4)° γ=103.543(4)°
2,2'-Bi-1,3-thiazolidine
C6H12N2S2
Acta Crystallographica Section E (2006) 62, 2 o525-o527
a=9.4931(6)Å b=5.0070(4)Å c=9.5942(8)Å
α=90° β=114.844(3)° γ=90°
C16H13NO5
C16H13NO5
Acta Crystallographica Section C (2004) 60, 6 o427-o430
a=9.7030(10)Å b=15.8560(10)Å c=18.8450(19)Å
α=90.00° β=101.962(5)° γ=90.00°
C16H13NO5
C16H13NO5
Acta Crystallographica Section C (2004) 60, 6 o427-o430
a=8.8590(10)Å b=12.830(2)Å c=12.6150(10)Å
α=90.00° β=102.971(2)° γ=90.00°
Ethyl (E)-3-(2-hydroxyphenyl)-2-(morpholinocarbonyl)propenoate
C16H19NO5
Acta Crystallographica Section C (2004) 60, 7 o517-o519
a=7.790(2)Å b=9.971(2)Å c=10.832(2)Å
α=72.59(3)° β=74.79(3)° γ=75.64(3)°
Ethyl <i>N</i>-(2-acetylphenyl)oxalamate
C12H13NO4
Acta Crystallographica Section C (2015) 71, 5 381-385
a=16.667(3)Å b=6.4800(10)Å c=10.241(2)Å
α=90° β=90° γ=90°
Ethyl 6-chloro-2-oxo-2H-chromene-3-carboxylate
C12H9ClO4
Acta Crystallographica Section C (2007) 63, 4 o239-o242
a=5.7982(5)Å b=13.0702(12)Å c=15.5540(12)Å
α=90.00° β=108.191(3)° γ=90.00°
Ethyl 6-bromo-2-oxo-2H-chromene-3-carboxylate
C12H9BrO4
Acta Crystallographica Section C (2007) 63, 4 o239-o242
a=5.8432(6)Å b=13.2073(14)Å c=15.6959(15)Å
α=90.00° β=109.327(3)° γ=90.00°
C12H10O4,C7H6N2S
C12H10O4,C7H6N2S
Acta Crystallographica Section C (2003) 59, 10 o544-o546
a=9.360(2)Å b=9.109(2)Å c=21.242(4)Å
α=90.00° β=98.78(3)° γ=90.00°
1,2-Bis(4-bromophenyl)-1<i>H</i>-benzimidazole
C19H12Br2N2
Acta Crystallographica Section C (2014) 70, 1 55-59
a=7.6621(5)Å b=10.8241(7)Å c=11.0422(7)Å
α=105.078(6)° β=106.456(6)° γ=96.677(5)°
Bis[hydrotris(pyrazolyl)borato]magnesium(II) chloroform disolvate
C18H20B2MgN12,2CHCl3
Acta Crystallographica Section C (2006) 62, 4 m132-m135
a=14.3475(12)Å b=14.3475(12)Å c=14.3475(12)Å
α=90.00° β=90.00° γ=90.00°
Bis[hydrotris(pyrazolyl)borato]calcium(II) chloroform disolvate
C18H20B2CaN12,2CHCl3
Acta Crystallographica Section C (2006) 62, 4 m132-m135
a=14.6697(9)Å b=14.6697(9)Å c=14.6697(9)Å
α=90.00° β=90.00° γ=90.00°
Diethyl N,N':N,N'-bis(ethylene)dioxamate
C12H18N2O6
Acta Crystallographica Section C (2004) 60, 9 o699-o701
a=6.2258(15)Å b=13.660(3)Å c=8.656(2)Å
α=90.00° β=99.807(4)° γ=90.00°
Carbonyl(3-oxopenta-1,4-diene-1,5,-diyl)[tris(3,5-dimethyl-1<i>H</i>- pyrazol-1-yl-κ<i>N</i>^2^)methane]iridium(III) trifluoromethanesulfonate
C22H26IrN6O2,CF3O3S
Acta Crystallographica Section C (2012) 68, 12 m367-m369
a=13.1441(3)Å b=16.2686(2)Å c=14.0631(3)Å
α=90° β=115.506(3)° γ=90°
Ethyl N-phenyloxamate
C10H11NO3
Acta Crystallographica Section C (2003) 59, 10 o541-o543
a=7.8033(5)Å b=10.6424(7)Å c=13.2432(9)Å
α=108.4910(10)° β=96.0810(10)° γ=110.1650(10)°
4-(1,3-dioxo-2,3,3a,4,7,7a-hexahydro-1H-isoindol-2-yl)phenyl acetate
C16H15NO4
Acta Crystallographica Section C (2006) 62, 3 o125-o128
a=16.1630(10)Å b=6.5780(10)Å c=13.5830(10)Å
α=90° β=93.73(2)° γ=90°
C10H7NO3
C10H7NO3
Acta Crystallographica, Section C: Crystal Structure Communications (2004) 60, 10 o722-o726
a=5.8820(10)Å b=19.6940(10)Å c=7.49100(10)Å
α=90.00° β=91.715(10)° γ=90.00°
C10H7NO3
C10H7NO3
Acta Crystallographica, Section C: Crystal Structure Communications (2004) 60, 10 o722-o726
a=9.8191(19)Å b=9.905(2)Å c=18.320(4)Å
α=90.00° β=94.037(4)° γ=90.00°
4-nitro-1-oxo-2-{(<i>E</i>)-[2-(piperidin-1- yl)ethyl]iminiomethyl}cyclohexadienide
C14H19N3O3
Acta Crystallographica Section C (2009) 65, 1 o8-o10
a=10.5688(17)Å b=12.1887(19)Å c=12.6816(15)Å
α=90° β=114.696(10)° γ=90°
<i>N</i>,<i>N</i>'-Bis(4-aminobenzyl)oxalamide
C16H18N4O2
Acta Crystallographica Section E (2011) 67, 2 o398
a=10.7970(9)Å b=8.0930(8)Å c=17.9888(7)Å
α=90° β=110.151(10)° γ=90°
1,2,3,3',4',6'-Hexaacetyl-4,6-<i>O</i>-benzylidenesucrose
C31H38O17
Acta Crystallographica Section E (2011) 67, 2 o486
a=8.2018(2)Å b=18.6416(3)Å c=22.0994(5)Å
α=90° β=90° γ=90°
2-(4-Hydroxyphenyl)-1<i>H</i>-benzimidazol-3-ium chloride monohydrate
C13H11N2O,Cl,H2O
Acta Crystallographica Section E (2013) 69, 9 o1485-o1486
a=10.3225(5)Å b=16.3159(5)Å c=15.4618(8)Å
α=90.00° β=101.071(5)° γ=90.00°
(<i>E</i>)-4-Hydroxy-2-{[(2-phenylethyl)iminiumyl]methyl}phenolate
C15H15NO2
Acta Crystallographica Section E (2012) 68, 7 o2075
a=9.5010(19)Å b=12.936(3)Å c=12.551(4)Å
α=90° β=124.81(2)° γ=90°
5-Methyl-1,3-benzenediol-diethyl N,N'-(1,3-phenylene) dioxalamate complex
C21H24N2O8
Crystal Growth & Design (2014) 14, 2 628
a=4.9410(2)Å b=18.7803(5)Å c=11.2062(4)Å
α=90.00° β=97.223(3)° γ=90.00°
1,3-Benzenediol-diethyl N,N'-(1,3-phenylene)dioxalamate complex
C74H82N8O30
Crystal Growth & Design (2014) 14, 2 628
a=15.1465(4)Å b=17.4664(6)Å c=17.4943(5)Å
α=113.765(3)° β=108.654(2)° γ=98.054(2)°
4,6-di-tbutyl-1,3-benzenediol-diethyl N,N'-(1,3-phenylene)dioxalamate
C29H39Cl3N2O8
Crystal Growth & Design (2014) 14, 2 628
a=15.8182(7)Å b=18.9181(6)Å c=11.3683(4)Å
α=90.00° β=92.369(4)° γ=90.00°
2-(1,3-dioxo-2,3,3a,4,7,7a-hexahydro-1H-isoindol-2-yl)phenyl acetate
C16H15NO4
Acta Crystallographica Section C (2006) 62, 3 o125-o128
a=9.6673(7)Å b=9.6787(7)Å c=15.5880(18)Å
α=90° β=107.131(2)° γ=90°